Proteomic profiling of follicular fluid-derived small extracellular vesicle-enriched preparations reveals altered molecular signatures associated with polyendocrine metabolic ovarian syndrome

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), is a major cause of anovulatory infertility. However, alterations in extracellular vesicle-associated proteins within the follicular microenvironment remain poorly understood. Follicular fluid-derived small extracellular vesicle (FF-sEV)-enriched preparations were isolated by ultracentrifugation from pooled samples of 18 women with PMOS and 15 controls. Preparations were characterized by transmission electron microscopy, nano-flow cytometry, and EV-associated marker detection. Label-free LC-MS/MS was performed in three technical replicates, and candidate differentially abundant proteins were screened using fold-change and nominal p -value thresholds. Among 4,419 identified proteins, 224 met the exploratory differential abundance criteria, including 73 with increased and 151 with decreased abundance in PMOS. None remained statistically significant after false discovery rate (FDR) correction. Functional enrichment analyses highlighted mitochondrial energy metabolism, endoplasmic reticulum-associated protein homeostasis, and lipid/sterol metabolism. Six proteins (CISD2, CYP51A1, PGRMC2, GSTK1, ATP5MF, and RRBP1) were prioritized for further investigation. Western blotting of individual samples from an independent cohort ( n = 3 per group) supported the decreased abundance of CISD2, CYP51A1, and PGRMC2 in PMOS. This exploratory study identified candidate protein abundance differences between pooled PMOS and control FF-sEV-enriched preparations, with preliminary support from independent Western blot validation. Further validation in larger independent cohorts is warranted.

Authors

Institutions

Publication Details

Journal
BMC Women s Health
Published
2026-11-19
DOI
https://doi.org/10.1186/s12905-026-05140-4
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Proteomic profiling of follicular fluid-derived small extracellular vesicle-enriched preparations reveals altered molecular signatures associated with polyendocrine metabolic ovarian syndrome

Zhou Zheng, Xinyue Lin, Fanggui Wu, Yongting Wu et al.
BMC Women s Health
Extracellular vesicles in disease
article

Proteomic profiling of follicular fluid-derived small extracellular vesicle-enriched preparations reveals altered molecular signatures associated with polyendocrine metabolic ovarian syndrome

Zhou Zheng, Xinyue Lin, Fanggui Wu, Yongting Wu, Weiling Zhao, Junjie Nie, Qian Feng, Shangjie Liu
article en

Abstract

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), is a major cause of anovulatory infertility. However, alterations in extracellular vesicle-associated proteins within the follicular microenvironment remain poorly understood. Follicular fluid-derived small extracellular vesicle (FF-sEV)-enriched preparations were isolated by ultracentrifugation from pooled samples of 18 women with PMOS and 15 controls. Preparations were characterized by transmission electron microscopy, nano-flow cytometry, and EV-associated marker detection. Label-free LC-MS/MS was performed in three technical replicates, and candidate differentially abundant proteins were screened using fold-change and nominal p -value thresholds. Among 4,419 identified proteins, 224 met the exploratory differential abundance criteria, including 73 with increased and 151 with decreased abundance in PMOS. None remained statistically significant after false discovery rate (FDR) correction. Functional enrichment analyses highlighted mitochondrial energy metabolism, endoplasmic reticulum-associated protein homeostasis, and lipid/sterol metabolism. Six proteins (CISD2, CYP51A1, PGRMC2, GSTK1, ATP5MF, and RRBP1) were prioritized for further investigation. Western blotting of individual samples from an independent cohort ( n = 3 per group) supported the decreased abundance of CISD2, CYP51A1, and PGRMC2 in PMOS. This exploratory study identified candidate protein abundance differences between pooled PMOS and control FF-sEV-enriched preparations, with preliminary support from independent Western blot validation. Further validation in larger independent cohorts is warranted.

BMC Women s Health
Shenzhen University (CN), Shantou University (CN), Shantou University Medical College (CN), Shenzhen Luohu People's Hospital (CN)
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon